Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1056/NEJMp1607378 | DOI Listing |
Front Pain Res (Lausanne)
October 2024
Department of Biomedical Engineering, Cleveland Clinic Foundation, Cleveland, OH, United States.
To an individual, pain is unambiguously real. To a caregiver, assessing pain in others is a challenging process shrouded in doubt. To explain this challenge, many assume that pain "belongs" exclusively to the bearer of that experience and accept the dogma that pain is private.
View Article and Find Full Text PDFNeurobiol Learn Mem
November 2024
Decision Neuroscience Laboratory, School of Psychology, UNSW Sydney, Australia. Electronic address:
Eur Rev Med Pharmacol Sci
November 2023
Department of Laboratory Medicine and Pathology, Azienda Unità Sanitaria Locale di Modena, Modena, Italy.
Objective: As of today, healthcare systems worldwide face severe challenges that undermine their sustainability. The value-based healthcare (VBHC) approach has been proposed as a strategic and methodological framework to ensure the delivery of the best patient outcomes with economic efficiency. Through the illustrative example of B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) for heart failure (HF) patient management in the context of the Italian National Healthcare system, this article explores the role that in vitro diagnostics (IVDs) can play in enabling value-based care models.
View Article and Find Full Text PDFFront Pharmacol
October 2023
KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.
Price erosion of generic medicines over time as a result of existing pricing policies in combination with increasing operational costs of these products due to high inflation, undermine long-term sustainable competition in European off-patent medicines markets. Therefore, the aim of this study is to identify new potential pricing models for retail generic medicines in Europe, examine their pros and cons, and illustrate them with examples inside or outside the pharmaceutical sector. A targeted literature review, one-to-one interviews and a joint advisory board meeting with experts from five European countries were carried out to assess potential pricing models for generic medicines.
View Article and Find Full Text PDFHealth Econ Policy Law
April 2024
VMLY&R Health, London, UK.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!